Idorsia In Dreamland With Insomnia Drug Approval
FDA Green Light For Daridorexant
The Swiss biotech has got the thumbs up in the US for its insomnia drug which will be sold as Quviviq and is expected to be provide serious competition for Merck & Co's rival dual orexin receptor antagonist Belsomra.
